Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL364P (RNA, 7SL, cytoplasmic 364, pseudogene) is a processed pseudogene related to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) complex. RN7SL364P does not encode a functional product and is not known to participate in biological pathways, regulatory networks, or disease processes. The 7SL RNA is essential for protein targeting to the endoplasmic reticulum, but RN7SL364P specifically is not a functional gene and is not considered a therapeutic, diagnostic, or biomarker target. Pseudogenes like RN7SL364P are abundant in the human genome; they arise from duplication or retrotransposition events and typically do not produce functional RNA or protein products[1][4][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 364, pseudogene (RN7SL364P).